The comparative long-term effects of ciladopa (AY-27,110), a chemically novel dopaminergic agonist, in 6-OHDA-lesioned and intact rats (Q34195512)

31 July 2017

title

The comparative long-term effects of ciladopa (AY-27,110), a chemically novel dopaminergic agonist, in 6-OHDA-lesioned and intact rats (English)

1 reference

31 July 2017

1 reference

K Voith

1

1 reference

31 July 2017

publication date

1 January 1985

1 reference

31 July 2017

1 reference

31 July 2017

volume

85

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

405-409

1 reference

Behavioral studies on the enantiomers of butaclamol demonstrating absolute optical specificity for neuroleptic activity

31 July 2017

cites work

1 reference

12 December 2020

Presynaptic subsensitivity as a possible basis for sensitization by long-tern dopamine mimetics

1 reference

12 December 2020

On the mode of action of apomorphine

1 reference

12 December 2020

Behavioral evidence for supersensitivity after chronic bromocriptine administration

1 reference

12 December 2020

Bromocriptine in Parkinson's disease: results obtained with high and low dose therapy.

1 reference

12 December 2020

The rotating rodent: A two component system?

1 reference

12 December 2020

Decreased responsiveness to low doses of apomorphine after dopamine agonists and the possible involvement of hyposensitivity of dopamine 'autoreceptors'

1 reference

12 December 2020

1 reference

12 December 2020

Behavioural and biochemical changes following chronic administration of L-dopa to rats

1 reference

12 December 2020

Behavioral facilitation following chronic administration of N-n-propylnorapomorphine

1 reference

12 December 2020

A pharmacological study of changes in central nervous system receptor responsiveness after long-term dexamphetamine and apomorphine administration

1 reference

12 December 2020

The effect of chronic bromocriptine and L-dopa on spiperone binding and apomorphine-induced stereotypy

1 reference

12 December 2020

Central deopaminergic receptor supersensitivity and its relevance to Parkinson's disease

1 reference

12 December 2020

Success and problems of long-term levodopa therapy in Parkinson's disease

1 reference

12 December 2020

The pharmacological evaluation of pergolide mesylate as a potential anti-parkinson agent

1 reference

12 December 2020

Chronic treatment with 1-dopa plus carbidopa in hemitransected rats: preferential effects at intact dopamine synapses leading to behavioural signs of dopamine receptor supersensitivity

1 reference

12 December 2020

Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system.

1 reference

12 December 2020

Bromocriptine-induced behavioral hypersensitivity: implications for the therapy of parkinsonism.

1 reference

12 December 2020

Biochemical alterations of dopamine receptor responses following chronic L-dopa therapy

1 reference

12 December 2020

Chronic L-DOPA treatment of mice: a behavioural and biochemical study

1 reference

12 December 2020

Parkinsonism and levodopa

1 reference

12 December 2020

Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism

1 reference

12 December 2020

Differentiation of apomorphine from bromocriptine, piribidel and TRH by chronic administration in rats

1 reference

12 December 2020

Central monoamine synapses as sites of action for ergot drugs

1 reference

12 December 2020

Dopamine receptor sensitivity after chronic dopamine agonists. Striatal 3H-spiroperidol binding in mice after chronic administration of high doses of apomorphine, N-n-propylnorapomorphine and dextroamphetamine

1 reference

12 December 2020

1 reference

12 December 2020

Bromocriptine: low-dose therapy in Parkinson disease

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00429654

1 reference

Dimensions Publication ID

31 July 2017

1049680893

0 references

1 reference